-
Tata India Pharma & Healthcare Fund Regular Rnvstmnt of Inc Dist cum Cap Wdrl
Equity healthcare
Overview ( as on 06/09/24 )
NAV
₹30.94
Last change
₹-0.16 -0.01%
Fund Size (AUM)
1056.02 Cr
Performance
28.31% (5Y)
Fund Details
Tata India Pharma & Healthcare Fund Regular Rnvstmnt of Inc Dist cum Cap Wdrl
as of 06/09/24
AUM
1056.02 Cr
Expense Ratio
2.18 %
Benchmark
Nifty Pharma TR INR
ISIN
INF277K018A5
Fund Manager
Meeta Shetty
Exit Load
0.25% if redeemed within 0-30 days
0% if redeemed after 30 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| Tata India Pharma & Healthcare Fund Regular Rnvstmnt of Inc Dist cum Cap Wdrl | 52.85% | 19.28% | 28.31% |
| Nifty Pharma TR INR | 54.79% | 17.57% | 27.38% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
13.1% |
Aurobindo Pharma Ltd |
10.06% |
Lupin Ltd |
9.24% |
Dr Reddy's Laboratories Ltd |
6.88% |
Cipla Ltd |
6.07% |
Zydus Lifesciences Ltd |
5.57% |
Divi's Laboratories Ltd |
4.89% |
Fortis Healthcare Ltd |
4.06% |
Alkem Laboratories Ltd |
3.78% |
Apollo Hospitals Enterprise Ltd |
3.69% |
Sector Allocation
Healthcare |
97.8% |
Basic Materials |
2.2% |
Asset Allocation
-
97%
Equity
-
3%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Gr
Equity healthcare-
Returns
-
31.75% (5Y)
-
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
29.87% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
29.88% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
28.86% (5Y)
-
-
Nippon India Pharma IDCW-P
Equity healthcare-
Returns
-
32.04% (5Y)
-
-
Nippon India Pharma IDCW-R
Equity healthcare-
Returns
-
32.04% (5Y)
-
